89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
89bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $9.73 per share as of 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2021-08-13
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.73.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.06.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.24.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.03.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2021-06-30 | $9.73 10-Q · filed 2021-08-13 |
| 2021-03-31 | $8.06 10-Q · filed 2021-05-14 |
| 2020-09-30 | $2.24 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.03 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.00 10-Q · filed 2020-05-13 |